Ascendis Pharma
ASND
$289.62
Share price
1.68%
Change (1 day)
20.21%
Change (1 year)
Categories
P/S ratio for Ascendis Pharma (ASND)
P/S ratio as of March 2025 (TTM): 25.7
According to Ascendis Pharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -90.7. At the end of 2024 the company had a P/S ratio of 21.2.
P/S ratio history for Ascendis Pharma from 2015 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 21.2 | -13.29% |
| 2023 | 24.5 | -81.16% |
| 2022 | 130 | -84.85% |
| 2021 | 857 | -23.38% |
| 2020 | > 1000 | 151.34% |
| 2019 | 445 | 104.12% |
| 2018 | 218 | -73.79% |
| 2017 | 832 | 546.84% |
| 2016 | 129 | 150.86% |
| 2015 | 51.3 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | 11.2 | -56.43% | 🇺🇸 USA |
 | 15.1 | -41.18% | 🇩🇪 Germany |
 | 3.47 | -86.50% | 🇺🇸 USA |